PSI CRO Broadens Global Reach by Further Expanding in Greece

PSI CRO, 11 June 2024 – PSI CRO has moved its base of operations in Greece to new offices in the heart of Athens. Located at Ermou 56, Athens 105 63, this new location expands PSI’s presence in the region while allowing the team to broaden site relationships and local expertise.

PSI opened its first Greek office in 2019 and remains committed to the growth and success of its team in the country. The company is dedicated to offering additional support and patient enrollment benefits with its expanded presence, maintaining its focus on on-time, on-budget and on-quality delivery of global pivotal trials across a variety of therapeutic areas.

We invite you to explore PSI’s unique CRO offering here.

About PSI: PSI CRO is a privately-owned, full-service clinical research organization (CRO) operating globally. PSI’s global reach supports clinical trials across multiple countries and continents and specializes in the planning and execution of global pivotal registration clinical trials. With an exceptionally high repeat and referral business rate combined with minimal staff turnover, PSI is committed to being the best CRO in the world as measured by its employees, customers, investigators, and vendors.

Global headquarters are located in Switzerland at 113a Baarerstrasse, Zug 6300. www.psi-cro.com

For Media Inquiries:

Ashley Collins, Marketing Specialist

919-972-9572 | ashley.stufanocollins@psi-cro.com

Share